RP is a lucky man, only one week to this quarter, a good new come out : Tamiflu is resistent to flu H1N1 , doctors should consider using RELENZA.
Shareholder's luck are on the way, hold on to your stock...flu season May to October in Australia ( BTA went up to $3.50)....maybe BOTA follow the BTA history, go up to $24.
My opinion only and believe to your destiny...